GERD & NERD Treatment Market 2018 Major Players: AstraZeneca Plc, Boston Scientific Corporation, Cempra Inc., Eisai Co., EndoGastric Solutions Inc., EndoStim Inc., GlaxoSmithKline Plc, Ironwood Pharmaceuticals

The, GERD & NERD Treatment Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The , GERD & NERD Treatment Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as esteem and volume.

TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5554 .

The Americas GERD & NERD treatment market is expected to grow at the CAGR of 4.02% during the forecast period 2017-2023

Synopsis of America GERD & NERD Treatment Market:

Over the last two hundred years, acid reflux has been a common lifestyle problem and also experienced a few setbacks in the U.S. Though, the ultimate goal of the gastroesophageal reflux treatment has always remained the same, which is to suppress the symptoms of the GERD patient. GERD affects up to 40% of the U.S. population in their lifetime and is a part of an increasingly significant public health burden. When GERD is not properly managed, it can lead to Barrett's esophagus. The lifetime risk of progression from GERD to Barrett's esophagus is 26.5%. Early diagnosis and treatment of Barrett's esophagus are crucial because it is the primary risk factor for esophageal cancer. The incidence of acid reflux disorder, also known as heartburn, is rapidly increasing worldwide. Various studies state that almost every person experiences acid reflux once in a lifetime. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.

The major driving factors for growth of the market are increasing cases of smoking, rising cases of reflux disorder during pregnancy, changing lifestyle, and irregular dietary habits. Moreover, increasing incidence of acid reflux disorder (heartburn), growing geriatric population are likely to fuel the market growth during the forecast period.

Key Players in the Americas GERD & NERD Treatment Market:

Some of the major players in this market are: AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co. Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), and Sanofi (France).

Regional Analysis:

The American GERD & NERD treatment market is growing at a steady pace. North America contributed the largest share to the GERD & NERD treatment market owing to continuously increasing demand for the medical devices, increasing number of healthcare organization, and the presence of huge patient population. Increasing cases of smoking are projected to fuel in the Americas market. The South American region accounts the least share of the market.

Key Findings:

Antacids segment dominates the market with nearly 26.11% share of the Americas GERD & NERD treatment market
Americas GERD & NERD treatment market was estimated to be USD 2,350.37 million in 2016
Proton pump inhibitors segment is expected to be the second largest market, which is expected to reach USD 773.62 million by 2023
Segmentation:

The Americas GERD & NERD treatment market is segmented on the basis of drug class, dosage form, and by the end user.

On the basis of the drug class, the market is segmented into antacids (acid neutralizers), proton pump inhibitors, H2 receptor blocker, prokinetic agents, antidepressants, calcium channel blockers, and others. Proton pump inhibitors are further segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. H2 receptor blocker is further segmented into ranitidine, famotidine, cimetidine, nizatidine, and others. Prokinetic agents are further segmented into domperidone, metoclopramide, itopride, prucalopride, cisapride, benzamide, mosapride, erythromycin, and others.

Based on the dosage form, it is segmented into solid and liquid.

On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.

AVAIL AMAZING DISCOUNT ON REPPRT @ https://www.marketresearchfuture.com/check-discount/5554 .

MAJOR TABLE OF CONTENTS:
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 Definition 14
2.2 Scope Of The Study 14
2.2.1 Research Objective 14
2.2.2 Assumptions 14
2.2.3 Limitations 14

3 RESEARCH METHODOLOGY
3.1.1 Primary Research Methodology 17
3.1.2 Data Points Received From The Doctors/ Gastrologist: 17
3.1.3 Data Points Received From The Manufacturer/ Pharmaceutical Companies: 18
3.1.4 Data Points Received From Hospitals, Clinics: 18
3.1.5 Secondary Research Methodology 20
3.1.6 Market Share Analysis 22
3.1.7 Trade Analysis 22
3.1.8 Market Pricing Approach 22

4 MARKET DYNAMICS
4.1 Introduction 23
4.2 Drivers 24
4.2.1 Increasing Cases Of Smoking To Boost The Market Growth (Impact Weightage- 20%) 24
4.2.2 Rising Cases Of Reflux Disorder During Pregnancy (Impact Weightage- 15%) 25
4.2.3 Changing Lifestyle And Irregular Dietary Habits (Impact Weightage- 15%) 26
4.2.4 Increasing Incidence Of Acid Reflux Disorder (Heartburn) Will Boost The American GERD& NERD Treatment Market (Impact Weightage- 25%) 27
4.2.5 Growing Geriatric Population (Impact Weightage- 15%) 28
4.2.6 Increasing Demands For Endoscopy Biopsy Procedures For Early Diagnosis (Impact Weightage- 10%) 29
4.3 Restraints 30
4.3.1 Loss Of Patent Exclusivity And Lack Of Pipeline Drugs (Impact Weightage- 55%) 30
4.3.2 High Cost Of The Gastroscopes (Weightage Impact- 45%) 31
4.4 Opportunity 32
4.4.1 Development Of New Drugs 32
4.5 Mega Trends 32
4.6 Macroeconomic Indicators 32
4.7 Technology Trends & Assessment 33

5 MARKET FACTOR ANALYSIS
5.1 Porters Five Forces Model 34
5.1.1 Bargaining Power Of Suppliers 35
5.1.2 Bargaining Power Of Buyers 35
5.1.3 Threat Of New Entrants 35
5.1.4 Threat Of Substitutes 35
5.1.5 Intensity Of Rivalry 36
5.2 Value Chain Analysis 36
5.2.1 R&D 37
5.2.2 Manufacturing 37
5.2.3 Distribution & Sales 37
5.2.4 Post-Sales Monitoring 37
5.3 Demand & Supply: Gap Analysis 38
5.4 Pricing Analysis 38
5.5 Investment Opportunity Analysis 38

…CONTINUED

ASK ANY QUESTION @ https://www.marketresearchfuture.com/enquiry/5554 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.